Stock GILD GILEAD SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Gilead Sciences, Inc.

Equities

GILD

US3755581036

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
65.96 USD +2.14% Intraday chart for Gilead Sciences, Inc. +1.82% -18.58%
May. 09 Declaration of Voting Results by Gilead Sciences CI
May. 09 Declaration of Voting Results by Gilead Sciences CI

Chart calendar Gilead Sciences, Inc.

b5e50c23050b8a9b434.suI2fiVC0UWwrKzVeVYOKk68ffJonqypo9qA9_gA_nw.yoNlNGg2gRrg-MaNLBkjUB3TDYQt0MLh1J7nrrNxhAyLqBsNSwqFC9jl9Q~08c9243633df637b16bf82e1fcd68547

Upcoming events on Gilead Sciences, Inc.

2024-05-14 02:20 pm BofA Securities Health Care Conference
2024-05-15 10:30 am RBC Capital Markets Global Healthcare Conference
2024-05-23 05:00 pm American Society of Clinical Oncology Meeting - Abstract No: #e16500
2024-05-31 03:45 pm American Society of Clinical Oncology Annual Meeting - Abstract No: #LBA8500
2024-06-01 10:00 am American Society of Clinical Oncology Annual Meeting - Abstract No: #3029
2024-06-01 01:30 pm American Society of Clinical Oncology Annual Meeting - Abstract No: #433248
2024-06-01 02:30 pm American Society of Clinical Oncology Annual Meeting - Abstract No: #TPS4195
2024-06-01 04:00 pm American Society of Clinical Oncology Annual Meeting - Abstract No: #LBA1004
2024-06-02 09:00 am American Society of Clinical Oncology Annual Meeting - Abstract No: #3508
2024-06-02 10:00 am American Society of Clinical Oncology Annual Meeting - Abstract No: #TPS4618
2024-06-02 10:00 am American Society of Clinical Oncology Annual Meeting - Abstract No: #TPS6130
2024-06-02 10:00 am American Society of Clinical Oncology Annual Meeting - Abstract No: #TPS4627
2024-06-02 10:00 am American Society of Clinical Oncology Annual Meeting - Abstract No: #TPS1140
2024-06-02 10:00 am American Society of Clinical Oncology Annual Meeting - Abstract No: #1102
2024-06-02 10:00 am American Society of Clinical Oncology Annual Meeting - Abstract No: #1075

Past events on Gilead Sciences, Inc.

2024-05-08 01:00 pm Annual General Meeting
2024-04-25 04:30 pm Q1 2024 Earnings Call
2024-04-25 04:02 pm Q1 2024 Earnings Release
2024-03-14 10:00 am Investor Meeting
2024-03-13 Ex-dividend day
2024-03-13 11:15 am Barclays Global Healthcare Conference
2024-03-12 10:00 am Leerink Partners Global Biopharma Conference
2024-03-05 12:50 pm TD Cowen Health Care Conference
2024-03-02 Conference on Retroviruses and Opportunistic Infections
2024-02-06 05:00 pm Q4 2023 Earnings Call
2024-02-06 04:02 pm Q4 2023 Earnings Release
2024-01-08 01:30 pm JPMorgan Healthcare Conference
2023-12-13 Ex-dividend day
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract Number : 4884
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract Number : 5101
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract Number : 4869
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract Number : 4865
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract Number : 5100
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract Number : 4864
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract Number : 5082

Past dividends on Gilead Sciences, Inc.

2024-03-13 Quarterly 0.77 USD
2023-12-13 Quarterly 0.75 USD
2023-09-13 Quarterly 0.75 USD
2023-06-13 Quarterly 0.75 USD
2023-03-13 Quarterly 0.75 USD
2022-12-13 Quarterly 0.73 USD
2022-09-13 Quarterly 0.73 USD
2022-06-13 Quarterly 0.73 USD
2022-03-13 Quarterly 0.73 USD
2021-12-13 Quarterly 0.71 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		22 449
22 305
0.65%		24 689
24 482
0.84%		27 305
26 657
2.43%		27 281
26 518
2.88%		27 116
27 083
0.12%
27 598

EBITDA
Million USD		Released
Forecast
Spread 		12 468
13 029
-4.3%		13 184
13 142
0.32%		14 598
15 539
-6.05%		14 283
13 783
3.63%		13 177
13 123
0.41%
9 607

EBIT
Million USD		Released
Forecast
Spread 		11 064
11 571
-4.38%		11 704
11 599
0.9%		12 548
13 943
-10.01%		12 180
12 141
0.32%		10 484
10 687
-1.9%
7 345

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		5 160
5 333
-3.24%		1 669
1 636
2.01%		8 278
9 507
-12.92%		5 814
5 658
2.76%		6 859
7 323
-6.33%
1 552

Net income
Million USD		Released
Forecast
Spread 		5 386
4 292
25.5%		123
137
-10.03%		6 225
7 205
-13.6%		4 592
4 383
4.77%		5 665
5 872
-3.52%
403

EPS
USD		Released
Forecast
Spread 		4,22
3,43
23.14%		0,10
0,12
-16.23%		4,93
5,75
-14.19%		3,64
3,48
4.75%		4,50
4,69
-3.96%
0,35

Announcement Date04/02/2004/02/2101/02/2202/02/2306/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		6 590
6 279
4.96%		6 260
5 873
6.6%		7 042
6 133
14.82%		7 389
6 630
11.45%		6 352
6 326
0.41%		6 599
6 454
2.24%		7 051
6 800
3.69%		7 115
7 104
0.16%		6 686
6 349
5.31%
6 718


6 979


7 238


6 484


6 781

EBITDA
Million USD		Released
Forecast
Spread 		4 049
3 438
17.79%		3 195
3 183
0.38%		3 811
3 049
24.99%		3 227
2 865
12.63%		2 883
3 407
-15.38%		3 258
3 343
-2.54%		3 908
3 636
7.49%		3 427
3 495
-1.94%
-889


3 365


3 541


3 543







EBIT
Million USD		Released
Forecast
Spread 		3 524
3 060
15.15%		2 670
2 602
2.6%		3 286
2 529
29.91%		2 699
2 622
2.92%		2 243
2 658
-15.62%		2 277
2 776
-17.99%		3 224
3 060
5.37%		2 739
2 940
-6.84%		-1 117
-1 679
33.48%
2 688


2 890


2 911


2 605


2 729

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-152
2 158
-107.05%		1 503
1 664
-9.68%		2 432
1 674
45.28%		2 031
1 840
10.37%		1 300
1 900
-31.59%		1 588
1 969
-19.35%		2 318
2 275
1.91%		1 653
2 090
-20.89%		-4 486



1 802


2 126


2 248


2 197


2 270

Net income
Million USD		Released
Forecast
Spread 		19,0
1 611
-98.82%		1 144
1 367
-16.32%		1 789
1 248
43.39%		1 640
1 438
14.02%		1 010
1 587
-36.37%		1 045
1 545
-32.38%		2 180
1 801
21.07%		1 429
1 599
-10.66%		-4 170
-2 888
-44.38%
1 365


1 596


1 651


1 651


1 732

EPS
USD		Released
Forecast
Spread 		0,02
1,34
-98.5%		0,91
1,11
-17.89%		1,42
1,01
40.93%		1,30
1,15
13%		0,80
1,23
-34.75%		0,83
1,20
-30.93%		1,73
1,43
20.88%		1,14
1,28
-11.05%		-3,34
-1,92
-74.06%
1,10


1,27


1,31


1,24


1,32

Announcement Date28/04/2202/08/2227/10/2202/02/2327/04/2303/08/2307/11/2306/02/2425/04/24-----

Upcoming sector events for Gilead Sciences, Inc.

2024-05-12 PHARMANUTRA S.P.A.: Q1 2024 Earnings Release
2024-05-12 AARTI PHARMALABS LIMITED: Q4 2024 Earnings Release
2024-05-12 ROHTO PHARMACEUTICAL CO.,LTD.: Q4 2023 Earnings Release
2024-05-12 SHIONOGI & CO., LTD.: Q4 2023 Earnings Release
2024-05-12 MOCHIDA PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-05-12 SAWAI GROUP HOLDINGS CO., LTD.: Q4 2023 Earnings Release
2024-05-12 MEGA LIFESCIENCES: Q1 2024 Earnings Release
2024-05-12 ALMIRALL, S.A.: Q1 2024 Earnings Release
2024-05-12 JW PHARMACEUTICAL CORPORATION: Q1 2024 Earnings Release (Projected)
2024-05-12 DONGKOOK PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Gilead Sciences, Inc.

2024-05-10 11:01 am PIRAMAL PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-10 06:50 am ANI PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
2024-05-10 06:46 am NEULAND LABORATORIES LIMITED: Q4 2024 Earnings Release
2024-05-09 NIPPON SHINYAKU CO., LTD.: Q4 2023 Earnings Release
2024-05-09 KYORIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-05-09 JCR PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-05-09 TTY BIOPHARM COMPANY LIMITED: Q1 2024 Earnings Release (Projected)
2024-05-09 04:02 pm COLLEGIUM PHARMACEUTICAL, INC.: Q1 2024 Earnings Release
2024-05-09 09:58 am SCINOPHARM TAIWAN, LTD.: April 2024 Sales and Revenue Release
2024-05-09 09:06 am ABBOTT INDIA LIMITED: Q4 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GILD Stock
  4. Calendar Gilead Sciences, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW